Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial

Abstract

Background:

Probiotic functional foods are widely advertised to consumers primarily based on probiotic supplements.

Objective:

Determine if consumption of yogurt containing a high dose of probiotics improves health in children ages 1–3 years attending daycare/school centers.

Subjects/Methods:

Double-blinded, randomized, placebo-controlled, allocation concealment clinical trial. Setting: Outpatient participants in the Washington, DC area. Participants: 182 healthy children between the age of 1 and 3 years attending daycare/school at least 3 days a week. Intervention: Active was a strawberry yogurt-based drink supplemented with Bifidobacterium animalis ssp. lactis (B. lactis) BB-12. The placebo was indistinguishable from the active drink, differing only in absence of the probiotic BB-12. Primary objective was to determine if consumption of a probiotic-containing yogurt-based drink decreases absences due to illnesses from daycare for children ages 1–3 years. Secondary was to determine if probiotic-containing yogurt-based drink improves overall parental satisfaction due to decreased absences from work and an overall healthier child.

Results:

There were no significant differences in the days of missed school per group, with 51.9% in the active group and 47.1% in the placebo group missing at least 1 day of school throughout the study. Additionally, there were no differences in any secondary outcomes among the groups.

Conclusions:

Consumption of a yogurt-based drink delivering 1010 CFU of Bifidobacterium animalis ssp. lactis (B. lactis) BB-12 per day did not decrease the number of days missed of school due to an illness. Additional independent research on the potential of BB-12 to reduce illness in children needs to be conducted.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

Abbreviations

BB-12:

Bifidobacterium animalis ssp. lactis (B. lactis)

AE:

adverse events

SAE:

serious adverse events

References

  1. Alfaleh K, Bassler D (2008). Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev CD005496.

  2. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT (2005). Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 40, 28–37.

    Article  PubMed  Google Scholar 

  3. Fleming DW, Cochi SL, Hightower AW, Broome CV (1987). Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics 79, 55–60.

    CAS  PubMed  Google Scholar 

  4. Food and Agriculture Organization of the United Nations and World Health Organization (2001). Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Córdoba, Argentina, 1–4 October 2001.

  5. Fukushima Y, Li ST, Hara H, Terada A, Mitsuoka T (1997). Effect of follow-up formula containing Bifidobacteria (NAN BF) on fecal flora and fecal metabolites in healthy children. Biosci Microflora 16, 65–72.

    Article  Google Scholar 

  6. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T (1998). Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 39–44.

    Article  CAS  PubMed  Google Scholar 

  7. Haskins R (1989). Acute illness in day care: how much does it cost? Bull NY Acad Med 65, 319–343.

    CAS  Google Scholar 

  8. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L et al. (2001). Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322, 1327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S (2000). Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604–1610.

    Article  CAS  PubMed  Google Scholar 

  10. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076–1079.

    Article  CAS  PubMed  Google Scholar 

  11. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC (2009). Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124, e172–e179.

    Article  PubMed  Google Scholar 

  12. Lin JS, Chiu YH, Lin NT, Chu CH, Huang KC, Liao KW et al. (2009). Different effects of probiotic species/strains on infections in preschool children: a double-blind, randomized, controlled study. Vaccine 27, 1073–1079.

    Article  PubMed  Google Scholar 

  13. Malinen E, Matto J, Salmitie M, Alander M, Saarela M, Palva A (2002). PCR-ELISA II: analysis of Bifidobacterium populations in human faecal samples from a consumption trial with Bifidobacterium lactis Bb-12 and a galacto-oligosaccharide preparation. Syst Appl Microbiol 25, 249–258.

    CAS  PubMed  Google Scholar 

  14. Merenstein DJ, Foster J, D’Amico F (2009). A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 163, 750–754.

    Article  PubMed  Google Scholar 

  15. Ouwehand AC, Kurvinen T, Rissanen P (2004). Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study. Int J Food Microbiol 95, 103–106.

    Article  PubMed  Google Scholar 

  16. Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P (1999). The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 53, 179–184.

    CAS  PubMed  Google Scholar 

  17. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Tvede M et al. (2002). Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 21, 417–419.

    Article  PubMed  Google Scholar 

  18. Shonkoff JP (2003). From neurons to neighborhoods: old and new challenges for developmental and behavioral pediatrics. J Dev Behav Pediatr 24, 70–76.

    Article  PubMed  Google Scholar 

  19. Silverstein M, Sales AE, Koepsell TD (2003). Health care utilization and expenditures associated with child care attendance: a nationally representative sample. Pediatrics 111, e371–e375.

    Article  PubMed  Google Scholar 

  20. StataCorp (2005). Stata Statistical Software: Release 9. StataCorp LP: College Station, TX.

  21. Vanderhoof J, Whitney D, Antonson D (2000). In children receiving antibiotics, does coadministration of lactobacillus GG reduce the incidence of diarrhea? West J Med 173, 397.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ventura M, Reniero R, Zink R (2001). Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Applied and Environmental Microbiology 67, 2760–2765.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Weizman Z, Asli G, Alsheikh A (2005). Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115, 5–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Jaclyn N. McCallister, research assistant, CAPRICORN research coordinators Haewon Park and Tina Tan, for their invaluable help, without whom this study would not have occurred. Dr's Mirjana Curic and Dave McCoy from Chr. Hansen for their help in obtaining cultures and help throughout the study. We would also like to thank the Data Safety Monitoring Board, Dr Seiji Hayashi George Washington University; Dr David Meyers the Agency for Healthcare Research and Quality and Dr Susan Crystal-Mansour community representative. We are also indebted to Cathy Obits Program Manager of the Gerber Foundation and the entire Foundation for their help and financial support.

Study concept and design: Merenstein, Roberts, Petterson, Sanders.

Acquisition of data: Merenstein, Scriven, Herbin-Smith.

Analysis and interpretation of data: Merenstein, Scriven, Herbin-Smith, Roberts, Petterson, Sanders.

Initial Drafting of the manuscript: Merenstein, Scriven, Herbin-Smith.

Critical revision of the manuscript for important intellectual content: Roberts, Petterson, Sander.

Statistical analysis: Petterson, Merenstein.

Obtained funding: Merenstein.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D J Merenstein.

Ethics declarations

Competing interests

Dr Mary Ellen Sanders consults for numerous different probiotic manufacturers. No other authors report conflict of interest.

Additional information

Contributors: This study was funded by The Gerber Foundation. The Gerber Foundation supports research regarding the health and nutrition of infants and young children from 0 to 3 years of age. PI had full legal ability to publish any findings.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merenstein, D., Smith, K., Scriven, M. et al. The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial. Eur J Clin Nutr 64, 685–691 (2010). https://doi.org/10.1038/ejcn.2010.30

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2010.30

Keywords

This article is cited by

Search

Quick links